Cohen Neil Harris

Insider CIK 1840006 · CMMB interim CEO, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CMMB Chemomab Therapeutics Ltd.	S Sale	2026-08-28	2026-09-01	1,000	$2.80	$2.8K	33,000	SEC↗
CMMB Chemomab Therapeutics Ltd.	S Sale	2026-08-28	2026-09-01	1,000	$2.80	$2.8K	33,000	SEC↗
CMMB Chemomab Therapeutics Ltd.	S Sale	2026-08-27	2026-09-01	1,304	$2.85	$3.7K	34,000	SEC↗
CMMB Chemomab Therapeutics Ltd.	S Sale	2026-08-27	2026-09-01	1,304	$2.85	$3.7K	34,000	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2026-03-16	2026-09-01	5,172	—	$0	18,075	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2026-03-16	2026-09-01	5,172	—	$0	18,075	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2025-03-16	2026-09-01	3,821	—	$0	12,903	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2025-03-16	2026-09-01	3,821	—	$0	12,903	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2024-03-18	2026-09-01	2,520	—	$0	9,082	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2024-03-18	2026-09-01	2,520	—	$0	9,082	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2023-03-21	2026-09-01	1,714	—	$0	6,562	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2023-03-21	2026-09-01	1,714	—	$0	6,562	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2023-03-16	2023-03-23	6,875	—	$0	6,875	SEC↗
CMMB Chemomab Therapeutics Ltd.	S Sale	2022-11-16	2022-11-18	2,409	$2.00	$4.8K	10,000	SEC↗
CMMB Chemomab Therapeutics Ltd.	P Buy	2022-05-18	2022-05-19	2,000	$3.19	$6.4K	12,409	SEC↗
CMMB Chemomab Therapeutics Ltd.	P Buy	2022-03-14	2022-03-15	2,000	$4.20	$8.4K	6,409	SEC↗
CMMB Chemomab Therapeutics Ltd.	P Buy	2022-03-14	2022-03-15	2,000	$4.30	$8.6K	8,409	SEC↗
CMMB Chemomab Therapeutics Ltd.	P Buy	2022-03-14	2022-03-15	2,000	$4.56	$9.1K	10,409	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2022-03-07	2026-09-01	1,705	—	$0	4,848	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2022-03-07	2023-03-23	6,820	—	$0	6,820	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2022-03-07	2022-11-18	6,820	—	$0	6,820	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2022-03-07	2022-05-19	6,820	—	$0	6,820	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2022-03-07	2022-03-09	6,820	—	$0	6,820	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2022-03-07	2022-03-15	6,820	—	$0	6,820	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2022-03-07	2026-09-01	1,705	—	$0	4,848	SEC↗
CMMB Chemomab Therapeutics Ltd.	P Buy	2021-12-06	2021-12-08	2,000	$7.43	$14.9K	4,409	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-04-19	2026-09-01	2,971	—	$0	3,143	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-04-19	2023-03-23	11,884	—	$0	11,884	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-04-19	2022-11-18	11,884	—	$0	11,884	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-04-19	2022-05-19	11,884	—	$0	11,884	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-04-19	2022-03-15	11,884	—	$0	11,884	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-04-19	2021-04-21	11,884	—	$0	11,884	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-04-19	2026-09-01	2,971	—	$0	3,143	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-03-16	2023-03-23	688	—	$0	688	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-03-16	2022-11-18	688	—	$0	688	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-03-16	2022-05-19	688	—	$0	688	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2021-03-16	2022-03-15	688	—	$0	688	SEC↗
CMMB Chemomab Therapeutics Ltd.	P Buy deriv	2021-03-16	2021-03-26	688	—	$0	688	SEC↗
CMMB Chemomab Therapeutics Ltd.	P Buy	2021-03-16	2021-03-26	2,409	$41.51	$100.0K	2,409	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2020-07-16	2026-09-01	172	—	$0	172	SEC↗
ANCN Anchiano Therapeutics Ltd.	A Award deriv	2020-07-16	2021-03-11	55,000	—	$0	55,000	SEC↗
CMMB Chemomab Therapeutics Ltd.	A Award deriv	2020-07-16	2026-09-01	172	—	$0	172	SEC↗